investment analyst coverage
BTIG Initiates Coverage of DermTech With Buy Rating
The investment bank said DermTech's pigmented lesion assay for the early detection of melanoma is well positioned in an estimated $3 billion-plus market.
Investment Banks Initiate Coverage of Talis Biomedical With Bullish Outlooks
Talis, which went public last month, develops point-of-care infectious disease tests based on its flagship Talis One sample-to-answer platform.
Barclays Initiates Coverage of Danaher, Ortho, and Thermo Fisher With Overweight Ratings
Danaher’s guidance of double-digit top-line growth for 2021 provides upside opportunities that depend mostly on the success of vaccine rollouts, Barclays said.
Oppenheimer Initiates Coverage of MDxHealth at Outperform
The investment bank cited its expectation for a positive coverage decision from Medicare for the company's SelectMDx prostate cancer test, among other reasons.
William Blair Initiates Coverage of Point-of-Care MDx Firm Lucira Health With Outperform Rating
The investment bank said that Lucira's COVID-19 single-use test could have widespread use with potential for adoption in the over-the-counter markets.